nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledgements
|
|
|
2010 |
|
6 |
p. 391-391 |
artikel |
2 |
Acknowledgements
|
|
|
2009 |
|
6 |
p. 413-413 |
artikel |
3 |
Aminoglycoside-induced mutation suppression (stop codon readthrough) as a therapeutic strategy for Duchenne muscular dystrophy
|
Malik, Vinod |
|
2010 |
|
6 |
p. 379-389 |
artikel |
4 |
An update on the evidence base for peginterferon β1a in the treatment of relapsing–remitting multiple sclerosis
|
Bhargava, Pavan |
|
2016 |
|
6 |
p. 483-490 |
artikel |
5 |
An update on the management of chronic inflammatory demyelinating polyneuropathy
|
Gorson, Kenneth C. |
|
2012 |
|
6 |
p. 359-373 |
artikel |
6 |
An update on the management of post-traumatic headache
|
Obermann, Mark |
|
2015 |
|
6 |
p. 311-315 |
artikel |
7 |
A practical approach to the diagnosis and management of sleep disorders in patients with multiple sclerosis
|
Braley, Tiffany J. |
|
2015 |
|
6 |
p. 294-310 |
artikel |
8 |
Assessment scales in dementia
|
Sheehan, Bart |
|
2012 |
|
6 |
p. 349-358 |
artikel |
9 |
Benefit of repetitive intrathecal triamcinolone acetonide therapy in predominantly spinal multiple sclerosis: prediction by upper spinal cord atrophy
|
Lukas, Carsten |
|
2009 |
|
6 |
p. 349-355 |
artikel |
10 |
Brivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence base
|
Brandt, Christian |
|
2016 |
|
6 |
p. 474-482 |
artikel |
11 |
Corrigendum
|
|
|
2015 |
|
6 |
p. 339 |
artikel |
12 |
Efficacy and safety of laquinimod in multiple sclerosis: current status
|
Haggiag, Shalom |
|
2013 |
|
6 |
p. 343-352 |
artikel |
13 |
Efficacy and tolerability of dimethyl fumarate in White-, African- and Hispanic- Americans with multiple sclerosis
|
Zhovtis Ryerson, Lana |
|
2016 |
|
6 |
p. 454-461 |
artikel |
14 |
Erratum
|
|
|
2012 |
|
6 |
p. 375-375 |
artikel |
15 |
Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome
|
Freedman, Mark S. |
|
2014 |
|
6 |
p. 279-288 |
artikel |
16 |
Evidence for the use of pimavanserin in the treatment of Parkinson’s disease psychosis
|
Sarva, Harini |
|
2016 |
|
6 |
p. 462-473 |
artikel |
17 |
Evolving expectations around early management of multiple sclerosis
|
Gold, Ralf |
|
2010 |
|
6 |
p. 351-367 |
artikel |
18 |
Future perspectives in target-specific immunotherapies of myasthenia gravis
|
Dalakas, Marinos C. |
|
2015 |
|
6 |
p. 316-327 |
artikel |
19 |
High noon back pain- severe pseudoradicular pain as a lead symptom of superficial siderosis: a case report
|
Saft, Carsten |
|
2014 |
|
6 |
p. 276-278 |
artikel |
20 |
Kynurenines and other novel therapeutic strategies in the treatment of dementia
|
Majláth, Zsófia |
|
2013 |
|
6 |
p. 386-397 |
artikel |
21 |
Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome
|
Schoonjans, An-Sofie |
|
2015 |
|
6 |
p. 328-338 |
artikel |
22 |
Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes
|
Lycke, Jan |
|
2015 |
|
6 |
p. 274-293 |
artikel |
23 |
MRI in the assessment and monitoring of multiple sclerosis: an update on best practice
|
Kaunzner, Ulrike W. |
|
2017 |
|
6 |
p. 247-261 |
artikel |
24 |
Neurochemical biomarkers in Alzheimer’s disease and related disorders
|
Bibl, Mirko |
|
2012 |
|
6 |
p. 335-348 |
artikel |
25 |
Notch signalling in adult neurons: a potential target for microtubule stabilization
|
Bonini, Sara Anna |
|
2013 |
|
6 |
p. 375-385 |
artikel |
26 |
Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis
|
Utz, Kathrin S. |
|
2014 |
|
6 |
p. 263-275 |
artikel |
27 |
Possible sites of action of the new calcitonin gene-related peptide receptor antagonists
|
Eftekhari, Sajedeh |
|
2010 |
|
6 |
p. 369-378 |
artikel |
28 |
Progressive multifocal leukoencephalopathy: current treatment options and future perspectives
|
Pavlovic, Dejan |
|
2015 |
|
6 |
p. 255-273 |
artikel |
29 |
Psychotic illness in patients with epilepsy
|
Kanemoto, Kousuke |
|
2012 |
|
6 |
p. 321-334 |
artikel |
30 |
Quetiapine in the treatment of psychosis in Parkinson’s disease
|
Shotbolt, Paul |
|
2010 |
|
6 |
p. 339-350 |
artikel |
31 |
Review: Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms
|
Awad, Amer |
|
2009 |
|
6 |
p. 357-368 |
artikel |
32 |
Review: Deep brain stimulation in Parkinson’s disease
|
Groiss, S.J. |
|
2009 |
|
6 |
p. 379-391 |
artikel |
33 |
Review: Identifying patient subtypes in multiple sclerosis and tailoring immunotherapy: challenges for the future
|
De Jager, Philip L. |
|
2009 |
|
6 |
p. 369-377 |
artikel |
34 |
Review: Improving symptom control in early Parkinson’s disease
|
Isaacson, Stuart H. |
|
2009 |
|
6 |
p. 393-400 |
artikel |
35 |
Review: Pathophysiology and treatment of bacterial meningitis
|
Hoffman, Olaf |
|
2009 |
|
6 |
p. 401-412 |
artikel |
36 |
Rituximab combination therapy in relapsing multiple sclerosis
|
Cross, Anne H. |
|
2012 |
|
6 |
p. 311-319 |
artikel |
37 |
Rituximab postprogressive multifocal leukoencephalopathy: a Feasible therapeutic option in selected cases
|
Hoepner, Robert |
|
2014 |
|
6 |
p. 289-291 |
artikel |
38 |
The case for dosing dabigatran: how tailoring dose to patient renal function, weight and age could improve the benefit–risk ratio
|
Safouris, Apostolos |
|
2015 |
|
6 |
p. 245-254 |
artikel |
39 |
The cognitive side of essential tremor: what are the therapeutic implications?
|
Janicki, Sarah C. |
|
2013 |
|
6 |
p. 353-368 |
artikel |
40 |
The role of neuroimaging in the diagnosis of headache disorders
|
Holle, Dagny |
|
2013 |
|
6 |
p. 369-374 |
artikel |
41 |
The role of pramipexole in a severe Parkinson’s disease model in mice
|
ElHak, Seham Gad |
|
2010 |
|
6 |
p. 333-337 |
artikel |
42 |
Two-year real-world experience with perampanel in patients with refractory focal epilepsy: Austrian data
|
Rohracher, Alexandra |
|
2016 |
|
6 |
p. 445-453 |
artikel |